CADL

SEC source: 0000950170-25-087698 · ownership.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087705 · ownership.xml · derivative · entry 1

Gaeta Renee · CIK 0001742428 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087708 · ownership.xml · derivative · entry 1

Benz Edward J. JR · CIK 0001691160 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087702 · ownership.xml · derivative · entry 1

Manning Paul B · CIK 0001494695 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087697 · ownership.xml · derivative · entry 1

PAPA JOSEPH C · CIK 0001242215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087703 · ownership.xml · derivative · entry 1

Loggia Nicoletta · CIK 0001979825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-087699 · ownership.xml · derivative · entry 1

Nabel Gary J. · CIK 0001867450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,240

Underlying: Common Stock · 14,240 shares

Expires 2035-06-17

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the "Board") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting.

SEC source: 0000950170-25-083163 · ownership.xml · derivative · entry 1

Radhakrishnan Maha · CIK 0002013423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0000950170-25-042725 · ownership.xml · nonDerivative · entry 2

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,740

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/19/2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 herein.

SEC source: 0000950170-25-042726 · ownership.xml · derivative · entry 3

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,822

Underlying: Common Stock · 18,000 shares

Expires 2030-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

F3 · derivative.exercise_date: 25% of the shares underlying this option vested and became exercisable on December 30, 2021, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0000950170-25-042726 · ownership.xml · nonDerivative · entry 2

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,527

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.345 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.

SEC source: 0000950170-25-042726 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,673

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

SEC source: 0000950170-25-042728 · ownership.xml · derivative · entry 5

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,095

Underlying: Common Stock · 13,905 shares

Expires 2033-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

F4 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-042728 · ownership.xml · derivative · entry 4

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 195,416

Underlying: Common Stock · 4,584 shares

Expires 2032-09-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

F3 · derivative.exercise_date: The first 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on September 12, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. The remaining 100,000 shares underlying this option shall vest as follows: 25% shall vest and become exercisable on the first anniversary of the date in which the Reporting Person converts to a full-time employee, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0000950170-25-042728 · ownership.xml · nonDerivative · entry 3

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,493

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.

SEC source: 0000950170-25-042728 · ownership.xml · nonDerivative · entry 2

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

SEC source: 0000950170-25-042728 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024.

SEC source: 0000950170-25-042725 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 226,140

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/19/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.33 to $9.01, inclusive.

SEC source: 0000950170-25-041991 · ownership.xml · nonDerivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,038

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.74 to $8.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.

SEC source: 0000950170-25-042002 · ownership.xml · derivative · entry 2

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 20,000 shares

Expires 2033-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

F3 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-042002 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,512

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.67 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.

SEC source: 0000950170-25-042724 · ownership.xml · derivative · entry 3

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 20,000 shares

Expires 2033-04-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

F3 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-042724 · ownership.xml · nonDerivative · entry 2

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,512

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.67 to $9.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 herein.

SEC source: 0000950170-25-042724 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/15/2024.

SEC source: 0001873919-25-000002 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,929

SEC source: 0001873919-25-000002 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 120,861

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

SEC source: 0000950170-25-021282 · ownership.xml · derivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2035-02-12

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-021287 · ownership.xml · derivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,000

Underlying: Common Stock · 83,000 shares

Expires 2035-02-12

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-021292 · ownership.xml · derivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2035-02-12

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-021284 · ownership.xml · derivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,250

Underlying: Common Stock · 107,250 shares

Expires 2035-02-12

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0000950170-25-021283 · ownership.xml · derivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 525,000

Underlying: Common Stock · 525,000 shares

Expires 2035-02-12

F1 · derivative.exercise_date: This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.

SEC source: 0001873919-25-000001 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · balance_after: Shares of common stock held jointly with spouse

SEC source: 0000950170-25-006726 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,673

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-006725 · ownership.xml · nonDerivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,038

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-006733 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,790

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-006723 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,320

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-006724 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,912

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-004200 · ownership.xml · nonDerivative · entry 1

Barone Francesca · CIK 0001909680 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,207

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-004199 · ownership.xml · nonDerivative · entry 1

Schoch Charles · CIK 0002007349 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,549

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-004197 · ownership.xml · nonDerivative · entry 1

Tyagarajan Seshu · CIK 0001923794 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,112

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-004195 · ownership.xml · nonDerivative · entry 1

Nichols William Garrett · CIK 0001618364 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,748

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0000950170-25-004198 · ownership.xml · nonDerivative · entry 1

Tak Paul Peter · CIK 0001873905 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,616

F1 · shares: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.

SEC source: 0001873919-24-000011 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 131,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

SEC source: 0001873919-24-000011 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,512

SEC source: 0001873919-24-000011 · primary_doc.xml · nonDerivative · entry 2

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 181,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

SEC source: 0001873919-24-000011 · primary_doc.xml · nonDerivative · entry 1

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,512

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 6

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 231,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 5

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,512

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 4

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By LKA 2022 Revocable Trust

Disclosed balance after: 281,443

F1 · ownership.nature: Shares of common stock held by spouse LKA 2022 Revocable trust

SEC source: 0001873919-24-000010 · primary_doc.xml · nonDerivative · entry 3

Aguilar-Cordova Estuardo · CIK 0001873919 · 10% owner

Aguilar Laura K. · CIK 0001873915 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,512